Objetivo
Communication strategy and tools for optimizing the impact of Ebola vaccination deployment.
The EBODAC consortium consists of 4 partners: Janssen (EFPIA), London School of Hygiene and Tropical Medicine (LSHTM), World Vision of Ireland and Grameen Foundation . These partners have experience and expertise in:
• (Ebola) vaccine development and vaccine acceptance; m-health deployments for disease management in resource limited settings (Janssen)
• Vaccine acceptance; risk management in health programs (LSHTM)
• Mobile health deployments for emergency assistance; communication and training delivery in emergency settings (World Vision)
• Mobile health software development and deployment in resource limited settings (Grameen)
As such, the EBODAC consortium is well placed to tackle the challenges associated with Ebola vaccine deployment, including:
• Stigma related to Ebola infections
• Lack of understanding and distrust versus vaccines in general in the local endemic communities
• Two step prime/booster regimen for Ebola vaccine: risk for a ‘no show’ for the booster shot, risk for presenting for the booster shot too early or too late; risk for a different person presenting for the booster shot vs. the prime shot
• People may be difficult to reach for the vaccine recall; People may live at a large distance from the health center where the vaccine is delivered
• Risk for data on vaccine coverage to be fragmented, not existing or incorrect
The EBODAC consortium is committed to deliver:
• A communication strategy that will optimize vaccine acceptance, supported by local anthropology research data
• A platform, based on mobile phone technology, for Ebola vaccine recalls, information/education on Ebola and vaccines in general; and tracking of vaccination coverage
• An identification tool to allow to match the identity of individuals in the prime and boost vaccine regimens
• A training program in the local setting, and a helpdesk function, to support the m-health platform
Ámbito científico (EuroSciVoc)
CORDIS clasifica los proyectos con EuroSciVoc, una taxonomía plurilingüe de ámbitos científicos, mediante un proceso semiautomático basado en técnicas de procesamiento del lenguaje natural.
CORDIS clasifica los proyectos con EuroSciVoc, una taxonomía plurilingüe de ámbitos científicos, mediante un proceso semiautomático basado en técnicas de procesamiento del lenguaje natural.
- ciencias médicas y de la saludciencias de la saludmedicina tropical
- ciencias médicas y de la saludmedicina básicainmunologíainmunización
- ciencias médicas y de la saludciencias de la saludenfermedad infecciosavirus de ARNébola
- ciencias médicas y de la saludmedicina básicafarmacología y farmaciamedicamentovacuna
- ingeniería y tecnologíaingeniería eléctrica, ingeniería electrónica, ingeniería de la informacióningeniería de la informacióntelecomunicaciónteléfono móvil
Para utilizar esta función, debe iniciar sesión o registrarse
Palabras clave
Programa(s)
Convocatoria de propuestas
H2020-JTI-IMI2-2014-02-single-stage
Consulte otros proyectos de esta convocatoriaRégimen de financiación
RIA - Research and Innovation actionCoordinador
WC1E 7HT London
Reino Unido